WELCOME TO FOROPTICSNZ LTD
ForOpticsNZ Ltd. (ForOptics), is the exclusive New Zealand distributor and service agent of the 3nethra neo and 3nethra neo HD FA. The Forus Health 3nethra neo and 3nethra neo HD FA are innovative, easy-to-use retinal cameras for screening Retinopathy of Prematurity and ocular diseases in infants. The 3nethra neo HD FA is a 150degree camera for fluorescein angiograms(FA).
ForOptics also offers a full-service Retinopathy of Prematurity screening nationwide and FA service.
PRODUCTS AVAILABLE FOR PURCHASE
The 3nethra neo and neo HD FA are compact, portable, and easy-to-use mydriatic wide-field digital imaging systems used for the photo documentation of ocular diseases that manifest in human eyes. The ergonomically designed, lightweight handpiece allows for single-handed operation and captures 120-degree images on the neo and 150-degree on the HD FA high-resolution images of the posterior and anterior segments of the eye. The device acquires only digital photographs of the eye and does not provide any analysis or diagnosis. The contact device is easily operated by qualified technicians and can be deployed in versatile clinical environments such as hospitals, operating rooms, Neonatal Intensive Care Units (NICU), and Special Care Baby Units (SCBU).
3NETHRA NEO AND 3NETHRA NEO HD FA NEONATAL RETINAL
Advanced mobile retinal imaging equipment for infants.
ABOUT US
ROP affects our most vulnerable children, our premature babies. These babies come into the world already fighting for their lives. ROP is just one of the many hurdles they have to overcome. Retinopathy of Prematurity is a very preventable eye disease, however, it takes good monitoring with high-quality equipment (like the 3nethra neo) to observe and assess retinal changes and to take action when further treatment and intervention is required.
The 3nethra neo HD FFA is great for documentation of ocular diseases in infants and children. It can capture colour and fluorescein angiogram(FA) retinal images of the human eye. Ultra-wide-field fluorescein angiography can reveal areas of peripheral neovascularization and active leakage among infants.
We believe that innovation in technology and creative business models can help develop sustainable access to vision care for premature babies.
ForOptics is a medical technology company with the goal of creating a National Retinopathy of Prematurity (ROP) Screening program using the latest ophthalmic equipment. Currently, we have ROP services running at Taranaki, Hawkes Bay, Tauranga, Whakatane, Hutt Valley, Whanganui and Whangarei Hospitals.
Our FA service can come to your private clinics so you can do fluorescein angiogram under EUA on your patients with out waiting for space in the public system.